MabVax Hits Ch. 11, Blaming Alleged $27M Pump-And-Dump
Biotech company MabVax Therapeutics Holdings has filed for Chapter 11, saying the company was left with no way to raise new equity after being used as part of an alleged $27...To view the full article, register now.
Already a subscriber? Click here to view full article